AG000V1D

1308672-74-3 | Sulfatinib

Chemical structure of Sulfatinib, CAS 1308672-74-3
AG000V1D
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 1308672-74-3
Catalog Number AG000V1D(AGN-PC-0WGDC1)
Chemical Name Sulfatinib
IUPAC Name N-[2-(dimethylamino)ethyl]-1-[3-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]amino]phenyl]methanesulfonamide
InChI InChI=1S/C24H28N6O3S/c1-17-13-19-15-21(7-8-22(19)27-17)33-23-9-10-25-24(29-23)28-20-6-4-5-18(14-20)16-34(31,32)26-11-12-30(2)3/h4-10,13-15,26-27H,11-12,16H2,1-3H3,(H,25,28,29)
InChI Key TTZSNFLLYPYKIL-UHFFFAOYSA-N
MDL Number MFCD28359080
Molecular Formula C24H28N6O3S
Molecular Weight 480.5825
SMILES O=S(CC1=CC=CC(NC2=NC=CC(OC3=CC4=C(NC(C)=C4)C=C3)=N2)=C1)(NCCN(C)C)=O
UNII B2K5L1L8S9
Synonyms
Sulfatinib, 1308672-74-3, surufatinib, KDR-IN-1, HMPL012, N-(2-(dimethylamino)ethyl)-1-(3-((4-((2-methyl-1H-indol-5-yl)oxy)pyrimidin-2-yl)amino)phenyl)methanesulfonamide, UNII-B2K5L1L8S9, B2K5L1L8S9, 1816307-67-1, Benzenemethanesulfonamide, N-(2-(dimethylamino)ethyl)-3-((4-((2-methyl-1H-indol-5-yl)oxy)-2-pyrimidinyl)amino)-, Benzenemethanesulfonamide, N-[2-(dimethylamino)ethyl]-3-[[4-[(2-methyl-1H-indol-5-yl)oxy]-2-pyrimidinyl]amino]-, N-[2-(dimethylamino)ethyl]-1-[3-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]amino]phenyl]methanesulfonamide, Surufatinib [INN], Sulfatinib [WHO-DD], Sulfatinib; HMPL-012, GTPL9769, HMPL-012, SCHEMBL1822601, TTZSNFLLYPYKIL-UHFFFAOYSA-N, BCP14757, EX-A2524, KS-00000TW5, AKOS030632837, ZINC117218067, CS-5949, AK549548, HMPL-012;HMPL 012;HMPL012, HY-12297, VEGFR2 inhibitor [WO2011060746], N-(2-(dimethylamino) ethyl)-1-(3-((4-((2-methyl-1H-indol-5-yl)oxy)pyrimidin-2-yl)amino)phenyl)methanesulfonamide,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited